Roble Belko & Company’s Amdocs DOX Stock Holding History

Roble Belko & Company’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-92	Closed	-$6K	–	313
2017 Q1	$6K	Hold	92	–	–	﹤0.01%	246
2016 Q4	$5K	Buy	+92	New	+$5.43K	﹤0.01%	267

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Roble Belko & Company's DOX Position: Q2 2017 in Review

Roble Belko & Company sold out of Amdocs (DOX) in Q2 2017, closing a stake of 92 shares — an estimated $6K sold.

Roble Belko & Company first reported a position in DOX in Q4 2016 and held it in 2 quarters. The position peaked at $6K in Q1 2017. 359 funds tracked by Wall St. Rank hold DOX as of Q2 2017.

Roble Belko & Company reported no remaining Amdocs position as of Q2 2017 after selling out during the quarter.
Roble Belko & Company sold 92 Amdocs shares in Q2 2017, an estimated $6K.
Roble Belko & Company first reported a position in Amdocs in Q4 2016 and held it in 2 quarters.
Roble Belko & Company's Amdocs position peaked at $6K in Q1 2017.
359 funds tracked by Wall St. Rank held Amdocs as of Q2 2017.

Based on Roble Belko & Company's 13F filing for Q2 2017, filed 11 Aug 2017.